Acura Pharmaceuticals, Inc. – OTC:ACUR
Acura Pharmaceuticals stock price today
Acura Pharmaceuticals stock price monthly change
Acura Pharmaceuticals stock price quarterly change
Acura Pharmaceuticals stock price yearly change
Acura Pharmaceuticals key metrics
Market Cap | 3.25M |
Enterprise value | 4.01M |
P/E | -1.67 |
EV/Sales | 1.78 |
EV/EBITDA | -5.30 |
Price/Sales | 1.68 |
Price/Book | 27.98 |
PEG ratio | -0.02 |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -51.27% |
Oper. margin | -49.35% |
Gross margin | 0% |
EBIT margin | -49.35% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAcura Pharmaceuticals stock price history
Acura Pharmaceuticals stock forecast
Acura Pharmaceuticals financial statements
| Dec 2022 | 0 | 0 | |
|---|---|---|---|
| Mar 2023 | 0 | 0 | |
| Jun 2023 | 0 | 0 | |
| Sep 2023 | 0 | 0 |
| Dec 2021 | 860000 | 682K | 79.3% |
|---|---|---|---|
| Mar 2023 | 0 | 0 | |
| Jun 2023 | 0 | 0 | |
| Sep 2023 | 0 | 0 |
| Dec 2022 | 0 | 0 | 0 |
|---|---|---|---|
| Mar 2023 | 0 | 0 | 0 |
| Jun 2023 | 0 | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 |
Acura Pharmaceuticals alternative data
| Aug 2023 | 9 |
|---|---|
| Sep 2023 | 9 |
| Oct 2023 | 9 |
| Nov 2023 | 9 |
| Dec 2023 | 9 |
| Jan 2024 | 9 |
| Feb 2024 | 9 |
| Mar 2024 | 9 |
| Apr 2024 | 9 |
| May 2024 | 9 |
| Jun 2024 | 9 |
| Jul 2024 | 9 |
Acura Pharmaceuticals other data
| Period | Buy | Sel |
|---|---|---|
| Aug 2017 | 10800 | 0 |
| Dec 2017 | 2185734 | 2195734 |
| Insider | Compensation |
|---|---|
| Dr. Albert W. Brzeczko (1957) Vice President of Pharmaceutical Sciences of Acura Pharmaceutical Technologies, Inc. | $220,000 |
Mr. Peter A. Clemens (1953) Senior Vice President, Chief Financial Officer & Sec. | $200,000 |
| Mr. Robert B. Jones (1959) Chief Executive Officer, Pres & Director | $150,000 |
-
What's the price of Acura Pharmaceuticals stock today?
One share of Acura Pharmaceuticals stock can currently be purchased for approximately $0.05.
-
When is Acura Pharmaceuticals's next earnings date?
Unfortunately, Acura Pharmaceuticals's (ACUR) next earnings date is currently unknown.
-
Does Acura Pharmaceuticals pay dividends?
No, Acura Pharmaceuticals does not pay dividends.
-
How much money does Acura Pharmaceuticals make?
Acura Pharmaceuticals has a market capitalization of 3.25M.
-
What is Acura Pharmaceuticals's stock symbol?
Acura Pharmaceuticals, Inc. is traded on the OTC under the ticker symbol "ACUR".
-
What is Acura Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Acura Pharmaceuticals?
Shares of Acura Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Acura Pharmaceuticals's key executives?
Acura Pharmaceuticals's management team includes the following people:
- Dr. Albert W. Brzeczko Vice President of Pharmaceutical Sciences of Acura Pharmaceutical Technologies, Inc.(age: 68, pay: $220,000)
- Mr. Peter A. Clemens Senior Vice President, Chief Financial Officer & Sec.(age: 72, pay: $200,000)
- Mr. Robert B. Jones Chief Executive Officer, Pres & Director(age: 66, pay: $150,000)
-
How many employees does Acura Pharmaceuticals have?
As Jul 2024, Acura Pharmaceuticals employs 9 workers.
-
When Acura Pharmaceuticals went public?
Acura Pharmaceuticals, Inc. is publicly traded company for more then 17 years since IPO on 4 Feb 2008.
-
What is Acura Pharmaceuticals's official website?
The official website for Acura Pharmaceuticals is acurapharm.com.
-
Where are Acura Pharmaceuticals's headquarters?
Acura Pharmaceuticals is headquartered at 616 N. North Court, Palatine, IL.
-
How can i contact Acura Pharmaceuticals?
Acura Pharmaceuticals's mailing address is 616 N. North Court, Palatine, IL and company can be reached via phone at +84 77057709.
Acura Pharmaceuticals company profile:
Acura Pharmaceuticals, Inc.
acurapharm.comOTC
12
Drug Manufacturers—Specialty & Generic
Healthcare
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.
Palatine, IL 60067
CIK: 0000786947
ISIN: US00509L8028
CUSIP: 00509L802
